September 2006 - Exercise, dietary changes and medication have long been the cornerstones of managing type 2 diabetes. But few studies examine how exercise actually benefits these patients.

September 2006: Physicians prescribing new medication often do not communicate to patients important details, such as potential side effects, how long or how often to take the drug or the specific name of the medication, according to an article in the...

Test Your Knowledge Issue 332

Last time Sheri Colberg, Ph.D., FACSM had some great insight as to why patients do not lose weight even though they exercise. This week she helps you give your patients a proper start. Learn what to do by reading Getting Started Is the Hardest Part. ...

Evaluation of a campaign that screened a community of 95,000 via 530 pharmacies.

The expected 1 Billion dollar market for CGMS (Continuious Blood Glucose Monitor), will soon have another competitor to compete with MiniMed and DexCom, it’s the Navigator from Abbott Diabetes Care. This was one of the main reasons Abbott bought...

Breast-feeding your baby can cut your risk of developing type 2 diabetesby15% a year and reduce the risk of breast and ovarian cancer.

According to a new report from Decision Resources, the New Novel Drug Classes Will Account for 76% of the Type 2 Diabetes Market by 2020, even though they are not even available in the US at this time.

Having either a large waistline or being overweight raises a person's risk of developing type 2 diabetes, but the combination of the two is most dangerous, a study shows.

Eating just one salad a day provides even greater health benefits than previously thought.

Only 32% of patients could correctly calculate the amount of carbohydrates consumed in a 20-ounce properly labeled bottle of soda that had 2.5 servings in the bottle.

A series of fairly low-tech innovations radically transformed diabetes care in a busy family medicine program in just over a year's time, exceeding insurance company pay-for-performance benchmarks.

Many patients stop taking their medicine far sooner than they should, researchers say, and that decision can be deadly when the drugs treat heart disease or diabetes. Two new studies show that nonadherence to medication is common among recent MI...

The hope for a cure fails: Two years after receiving transplants of insulin-producing beta islet cells, only five of 36 patients with type 1 diabetes remained free of the need for insulin injections.

Doxazosin appears to work synergistically with acarbose to improve metabolic control in patients with impaired glucose tolerance.

Findings from a new study suggest that obesity per se is not a risk factor for acute organ failure or death. However, diabetes, which often develops in obese individuals, does increase the risk.

Benfotiamine prevents the endothelial dysfunction and oxidative stress that follow a meal rich in advanced glycation end (AGE) products in type 2 diabetics.

One in three adults with CVD was vaccinated against flu in 2005. One of the biggest barriers is that only about half of all cardiologists in the US stock flu vaccine in their clinics.

Orexigen Therapeutics announced that top-line results for the company's lead obesity compound, Contrave™, demonstrated significant advantages in weight loss in a 24-week multicenter, placebo-controlled, Phase III trial. The trial will continue u...